Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-23

FDA Approved: BUPRENORPHINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

FDA approved a supplemental application for buprenorphine by Sun Pharmaceutical Industries, Inc., through an ANDA supplement to modify or add to the approved pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • buprenorphine (buprenorphine)

Snippet

SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)